Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-28
DOI
10.1038/s41419-021-03827-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
- (2019) Pablo Fernández-Tussy et al. Molecular Metabolism
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
- (2018) David Fernández-Ramos et al. Cell Death & Disease
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma
- (2017) Shibo Lin et al. JOURNAL OF PINEAL RESEARCH
- Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication
- (2017) Mairene Coto-Llerena et al. VIRUS RESEARCH
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
- (2015) Erica Villa et al. GUT
- Mitochondrial ROS and cancer drug resistance: Implications for therapy
- (2015) Imoh S. Okon et al. PHARMACOLOGICAL RESEARCH
- Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
- (2015) Lucía Barbier-Torres et al. Oncotarget
- MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
- (2015) Changjun He et al. Oncotarget
- Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt’s lymphoma B cells
- (2015) Gorbatchev Ambroise et al. Oncotarget
- The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
- (2015) Valentina Tesori et al. Scientific Reports
- Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
- (2013) Elisa Herraez et al. HEPATOLOGY
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
- (2012) Y-C Shen et al. BRITISH JOURNAL OF CANCER
- MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
- (2012) Claudia Augello et al. LIVER INTERNATIONAL
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
- (2012) C Dudgeon et al. ONCOGENE
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
- (2011) Inthrani R. Indran et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
- (2011) Sara Toffanin et al. GASTROENTEROLOGY
- Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation
- (2011) Nieves Embade et al. HEPATOLOGY
- Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
- (2011) Joan Fernando et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant hep G2 cells through a mitochondria-dependent oxidative stress mechanism
- (2010) Jeng-Fong Chiou et al. CANCER BIOLOGY & THERAPY
- Induction of DNA Damage-Inducible Gene GADD45 Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2010) D.-L. Ou et al. CANCER RESEARCH
- MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2009) F. Fornari et al. CANCER RESEARCH
- JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
- (2009) Sophie C. Cazanave et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
- (2009) Shoumei Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- PUMA, a potent killer with or without p53
- (2009) J Yu et al. ONCOGENE
- MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors
- (2008) Chiara Braconi et al. HEPATOLOGY
- Identification of metastasis-related microRNAs in hepatocellular carcinoma
- (2008) Anuradha Budhu et al. HEPATOLOGY
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
- (2008) Yannick Ladeiro et al. HEPATOLOGY
- MicroRNA involvement in hepatocellular carcinoma
- (2008) Laura Gramantieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
- (2008) Qihong Huang et al. NATURE CELL BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started